Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.

Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol (2005) 3.28

Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev (2004) 2.73

Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol (2013) 2.58

Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens. Semin Cancer Biol (2009) 1.63

An in vitro microfluidic approach to generating protein-interaction networks. Nat Methods (2008) 1.59

Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem (2010) 1.54

Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J (2007) 1.52

Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev (2007) 1.49

Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem Sci (2012) 1.46

Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev (2012) 1.37

RB1, development, and cancer. Curr Top Dev Biol (2011) 1.37

Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc Natl Acad Sci U S A (2009) 1.31

Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts? Cell Div (2007) 1.22

Recruitment of Cln3 cyclin to promoters controls cell cycle entry via histone deacetylase and other targets. PLoS Biol (2009) 1.20

Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition. Mol Cell Biol (2007) 1.13

EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. J Biol Chem (2009) 1.13

Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Mol Biosyst (2009) 1.09

Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol Cell (2007) 1.09

p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis. Oncogene (2010) 1.06

Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. Cell Host Microbe (2014) 0.95

Crystal structure of the unliganded retinoblastoma protein pocket domain. Proteins (2011) 0.94

RB regulates pancreas development by stabilizing Pdx1. EMBO J (2011) 0.93

Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining. Cell Rep (2015) 0.92

Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture. Am J Ophthalmol (2014) 0.91

Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein. PLoS One (2013) 0.90

Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma. J Cancer Res Clin Oncol (2004) 0.89

MDMX exerts its oncogenic activity via suppression of retinoblastoma protein. Oncogene (2015) 0.88

Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain. J Mol Biol (2013) 0.87

Eye cancer: unique insights into oncogenesis: the Cogan Lecture. Invest Ophthalmol Vis Sci (2006) 0.86

Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration. Cell Cycle (2016) 0.85

Somatic alterations in brain tumors. Oncol Rep (2008) 0.85

Paradoxical instability-activity relationship defines a novel regulatory pathway for retinoblastoma proteins. Mol Biol Cell (2010) 0.85

Structural mechanisms of DREAM complex assembly and regulation. Genes Dev (2015) 0.84

A comparative study of Whi5 and retinoblastoma proteins: from sequence and structure analysis to intracellular networks. Front Physiol (2014) 0.81

Small-molecule regulators that mimic transcription factors. Biochim Biophys Acta (2010) 0.80

Rbf1 degron dysfunction enhances cellular DNA replication. Cell Cycle (2012) 0.80

Conformational dissection of a viral intrinsically disordered domain involved in cellular transformation. PLoS One (2013) 0.79

Phosphorylation puts the pRb tumor suppressor into shape. Genes Dev (2012) 0.79

Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97. J Biol Chem (2015) 0.78

Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain. J Biol Chem (2013) 0.76

PRMT4-mediated arginine methylation negatively regulates retinoblastoma tumor suppressor protein and promotes E2F-1 dissociation. Mol Cell Biol (2014) 0.76

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB. Genes Cancer (2016) 0.75

Multiple molecular interactions redundantly contribute to RB-mediated cell cycle control. Cell Div (2017) 0.75

Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort. Mol Vis (2016) 0.75

Structural and functional characterization of the acidic region from the RIZ tumor suppressor. Biochemistry (2015) 0.75

Clefts, grooves, and (small) pockets: the structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled. Proc Natl Acad Sci U S A (2003) 0.75

Retinoblastoma family proteins: New players in DNA repair by non-homologous end-joining. Mol Cell Oncol (2015) 0.75

Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family. J Mol Biol (2016) 0.75

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer. BMC Cancer (2014) 0.75

A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection. Bull Math Biol (2017) 0.75

The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88

Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28

Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63

The retinoblastoma protein and cell cycle control. Cell (1995) 20.21

Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54

The regulation of E2F by pRB-family proteins. Genes Dev (1998) 12.77

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science (1996) 9.48

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19

Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75

Rb targets histone H3 methylation and HP1 to promoters. Nature (2001) 8.26

Rb interacts with histone deacetylase to repress transcription. Cell (1998) 7.22

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell (1989) 6.43

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26

The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev (2000) 5.93

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73

Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell (1997) 5.39

E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell (1996) 5.26

The Rb/E2F pathway and cancer. Hum Mol Genet (2001) 4.98

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell (1999) 4.94

Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science (1992) 4.89

Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol (1998) 4.54

Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell (2000) 4.48

The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell (1991) 4.42

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A (1992) 4.27

Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14

Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol (1989) 4.10

Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (1995) 4.05

Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (2000) 3.83

The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75

Cell cycle regulation of the human cdc2 gene. EMBO J (1992) 3.69

E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci U S A (1989) 3.67

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54

Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47

E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol (1996) 3.40

Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci U S A (2002) 3.28

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell (1990) 3.19

A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J (1990) 3.07

Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature (1998) 3.01

Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol (2000) 2.84

Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82

The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80

Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science (1993) 2.70

E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61

Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53

Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell (1999) 2.48

Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48

Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells. Mol Cell Biol (1991) 2.42

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci U S A (1996) 2.36

Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science (1997) 2.35

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol (1990) 2.27

Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26

Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J (1990) 2.26

E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol (1995) 2.26

The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res (1993) 2.17

Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J (2001) 1.93

A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol Cell Biol (1993) 1.70

Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol Cell (1999) 1.69

Regulation of transcription by proteins that control the cell cycle. Nature (1997) 1.68

Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A (1997) 1.67

Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci U S A (1992) 1.54

E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc Natl Acad Sci U S A (1996) 1.52

The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res (1996) 1.47

Thymidine kinase transcription is regulated at G1/S phase by a complex that contains retinoblastoma-like protein and a cdc2 kinase. Proc Natl Acad Sci U S A (1992) 1.41

Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A (1998) 1.38

Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene (1997) 1.31

Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A (1996) 1.29

Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J Biol Chem (1999) 1.23

Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene (1994) 1.12

The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J Biol Chem (1994) 1.12

Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor. Rev Med Virol (2002) 0.95

Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res (2001) 0.94

Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell (2006) 11.98

The Characteristics of Cultural Conditions for the Mycelial Growth of Macrolepiota procera. Mycobiology (2005) 2.55

T-DNA insertional mutagenesis for activation tagging in rice. Plant Physiol (2002) 1.99

Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9-AdoMet. EMBO J (2003) 1.89

Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell (2003) 1.78

Crystal structure of human DGCR8 core. Nat Struct Mol Biol (2007) 1.74

Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol Cell Biol (2006) 1.67

Formate-driven growth coupled with H(2) production. Nature (2010) 1.57

Structural basis for inhibition of the replication licensing factor Cdt1 by geminin. Nature (2004) 1.50

Crystal structure of the Mre11-Rad50-ATPγS complex: understanding the interplay between Mre11 and Rad50. Genes Dev (2011) 1.45

Cloning and characterization of a new cold-active lipase from a deep-sea sediment metagenome. Appl Microbiol Biotechnol (2008) 1.41

One-step sequence- and ligation-independent cloning as a rapid and versatile cloning method for functional genomics studies. Appl Environ Microbiol (2012) 1.33

Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery. Chem Commun (Camb) (2008) 1.31

Crystal structure of the human rad9-hus1-rad1 clamp. J Mol Biol (2009) 1.27

Structural basis for the NAD-dependent deacetylase mechanism of Sir2. J Biol Chem (2002) 1.26

A mammalian pre-mRNA 5' end capping quality control mechanism and an unexpected link of capping to pre-mRNA processing. Mol Cell (2013) 1.25

Crystal structure of the human GINS complex. Genes Dev (2007) 1.25

Crystal structure of the eIF4A-PDCD4 complex. Proc Natl Acad Sci U S A (2009) 1.23

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) (2006) 1.20

Alternating translocation of protein substrates from both ends of ClpXP protease. EMBO J (2002) 1.14

Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. J Clin Invest (2009) 1.12

Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J Nutr (2005) 1.11

Crystal structure of human Mre11: understanding tumorigenic mutations. Structure (2011) 1.10

Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci. Cancer (2006) 1.10

ClpA and ClpX ATPases bind simultaneously to opposite ends of ClpP peptidase to form active hybrid complexes. J Struct Biol (2004) 1.10

Structure of a peptide:N-glycanase-Rad23 complex: insight into the deglycosylation for denatured glycoproteins. Proc Natl Acad Sci U S A (2005) 1.05

Crystal structure of the Mus81-Eme1 complex. Genes Dev (2008) 1.04

Identification of a new subfamily of salt-tolerant esterases from a metagenomic library of tidal flat sediment. Appl Microbiol Biotechnol (2011) 1.02

Cloning and characterization of three epoxide hydrolases from a marine bacterium, Erythrobacter litoralis HTCC2594. Appl Microbiol Biotechnol (2007) 1.01

Preparation and characterization of chemically functionalized silica-coated magnetic nanoparticles as a DNA separator. J Phys Chem B (2009) 1.01

Crystal structure of Lon protease: molecular architecture of gated entry to a sequestered degradation chamber. EMBO J (2010) 1.00

Identification of a novel class of membrane-bound [NiFe]-hydrogenases in Thermococcus onnurineus NA1 by in silico analysis. Appl Environ Microbiol (2010) 0.98

CO-dependent H2 production by genetically engineered Thermococcus onnurineus NA1. Appl Environ Microbiol (2013) 0.98

Structural basis for dimerization and activity of human PAPD1, a noncanonical poly(A) polymerase. Mol Cell (2011) 0.98

Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor. Rev Med Virol (2002) 0.95

Repair activities of human 8-oxoguanine DNA glycosylase are stimulated by the interaction with human checkpoint sensor Rad9-Rad1-Hus1 complex. DNA Repair (Amst) (2009) 0.93

H2 production from CO, formate or starch using the hyperthermophilic archaeon, Thermococcus onnurineus. Biotechnol Lett (2011) 0.91

Cloning, expression, and characterization of a DNA ligase from a hyperthermophilic archaeon Thermococcus sp. Biotechnol Lett (2006) 0.90

Physicochemical Requirement for the Vegetative Growth of Schizophyllum commune Collected from Different Ecological Origins. Mycobiology (2008) 0.90

DDS, 4,4'-diaminodiphenylsulfone, extends organismic lifespan. Proc Natl Acad Sci U S A (2010) 0.89

Homomeric interaction of AtVSR1 is essential for its function as a vacuolar sorting receptor. Plant Physiol (2010) 0.89

Novel metagenome-derived carboxylesterase that hydrolyzes β-lactam antibiotics. Appl Environ Microbiol (2011) 0.89

Structure of the Cdt1 C-terminal domain: conservation of the winged helix fold in replication licensing factors. Protein Sci (2009) 0.87

Simultaneous determination of acetylsalicylic acid and caffeine in pharmaceutical formulation by first derivative synchronous fluorimetric method. J Fluoresc (2006) 0.86

Cardiac-specific Nkx2.5 homeodomain: conformational stability and specific DNA binding of Nkx2.5(C56S). Biochemistry (2005) 0.84

Therapeutic hypothermia attenuates liver injury in polymicrobial sepsis model of rats via Akt survival pathway. J Surg Res (2012) 0.84

Characterization of the frhAGB-encoding hydrogenase from a non-methanogenic hyperthermophilic archaeon. Extremophiles (2014) 0.84

Probing the roles of active site residues in the 3'-5' exonuclease of the Werner syndrome protein. J Biol Chem (2007) 0.84

Crystal structure of the NurA-dAMP-Mn2+ complex. Nucleic Acids Res (2011) 0.83

Label-free electrochemical detection of the p53 core domain protein on its antibody immobilized electrode. Anal Chem (2009) 0.83

Selective enrichment of cysteine-containing peptides using SPDP-functionalized superparamagnetic Fe(3)O(4)@SiO(2) nanoparticles: application to comprehensive proteomic profiling. J Proteome Res (2008) 0.83

Effect of therapeutic hypothermia according to severity of sepsis in a septic rat model. Cytokine (2012) 0.82

Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling. Mol Cell Biol (2011) 0.82

Electrochemical DNA biosensors based on thin gold films sputtered on capacitive nanoporous niobium oxide. Biosens Bioelectron (2007) 0.82

Effect of Ag and Au nanoparticles on the SERS of 4-aminobenzenethiol assembled on powdered copper. J Phys Chem B (2005) 0.82

Crystal structures of the structure-selective nuclease Mus81-Eme1 bound to flap DNA substrates. EMBO J (2014) 0.81

Vegetative Growth of Four Strains of Hericium erinaceus Collected from Different Habitats. Mycobiology (2008) 0.81

Probing the functional importance of the hexameric ring structure of RNase PH. J Biol Chem (2003) 0.81

Enhancing immunoassay detection of antigens with multimeric protein Gs. Biosens Bioelectron (2011) 0.81

Thermodynamics of formate-oxidizing metabolism and implications for H2 production. Appl Environ Microbiol (2012) 0.80

Cloning, purification, and characterization of a new DNA polymerase from a hyperthermophilic archaeon, Thermococcus sp. NA1. J Microbiol Biotechnol (2007) 0.80

HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2. J Innate Immun (2015) 0.80

Structural basis for the β-lactamase activity of EstU1, a family VIII carboxylesterase. Proteins (2013) 0.80

The hsSsu72 phosphatase is a cohesin-binding protein that regulates the resolution of sister chromatid arm cohesion. EMBO J (2010) 0.80

Amino acid side chain-like surface modification on magnetic nanoparticles for highly efficient separation of mixed proteins. Talanta (2012) 0.79

Characterization of a dITPase from the hyperthermophilic archaeon Thermococcus onnurineus NA1 and its application in PCR amplification. Appl Microbiol Biotechnol (2008) 0.79

Novel lipolytic enzymes identified from metagenomic library of deep-sea sediment. Evid Based Complement Alternat Med (2011) 0.78

Combination antitumor effects of micelle-loaded anticancer drugs in a CT-26 murine colorectal carcinoma model. Int J Pharm (2009) 0.78

Repression of nascent strand elongation by deregulated Cdt1 during DNA replication in Xenopus egg extracts. Mol Biol Cell (2008) 0.78

Inorganic nanomaterial-based biocatalysts. BMB Rep (2011) 0.78

Silver-particle-based surface-enhanced resonance Raman scattering spectroscopy for biomolecular sensing and recognition. Anal Bioanal Chem (2007) 0.78

Enzyme-magnetic nanoparticle conjugates as a rigid biocatalyst for the elimination of toxic aromatic hydrocarbons. Chem Commun (Camb) (2011) 0.78

Rapid pathogen detection with bacterial-assembled magnetic mesoporous silica. Biosens Bioelectron (2013) 0.78

Screening of a novel strong promoter by RNA sequencing and its application to H2 production in a hyperthermophilic archaeon. Appl Microbiol Biotechnol (2015) 0.77

Sustained drug release on temperature-responsive poly(N-isopropylacrylamide)-integrated hydroxyapatite. Chem Commun (Camb) (2002) 0.77

Comparison of CO-dependent H₂ production with strong promoters in Thermococcus onnurineus NA1. Appl Microbiol Biotechnol (2013) 0.77

Rapid and selective separation for mixed proteins with thiol functionalized magnetic nanoparticles. Nanoscale Res Lett (2012) 0.77

Crystallization and preliminary X-ray crystallographic analysis of Lon from Thermococcus onnurineus NA1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.76

trans-10, cis-12 conjugated linoleic acid reduces insulin-like growth factor-II secretion in HT-29 human colon cancer cells. J Med Food (2003) 0.76

Critical factors to high thermostability of an alpha-amylase from hyperthermophilic archaeon Thermococcus onnurineus NA1. J Microbiol Biotechnol (2007) 0.76

Enhancing bio-hydrogen production from sodium formate by hyperthermophilic archaeon, Thermococcus onnurineus NA1. Bioprocess Biosyst Eng (2014) 0.76

Culture Conditions Affecting the Optimal Mycelial Growth of Cystoderma amianthinum. Mycobiology (2005) 0.75

Crystallization and preliminary X-ray crystallographic analysis of a novel histidinol-phosphate phosphatase from Thermococcus onnurineus NA1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.75

Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the central zinc-binding domain of the human Mcm10 DNA-replication factor. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.75

Crystallization and preliminary X-ray studies of TON_1713 from Thermococcus onnurineus NA1, a putative member of the haloacid dehalogenase superfamily. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75

Genes Expressed During Fruiting Body Formation of Agrocybe cylindracea. Mycobiology (2006) 0.75

Pathological features of bone marrow transplantation-related toxicity in a mouse. J Vet Sci (2009) 0.75

Enantioselective hydrolysis of racemic epichlorohydrin using an epoxide hydrolase from Novosphingobium aromaticivorans. J Biosci Bioeng (2010) 0.75

Sensing domain and extension rate of a family B-type DNA polymerase determine the stalling at a deaminated base. J Microbiol Biotechnol (2008) 0.75

Pharmacokinetics of verproside after intravenous and oral administration in rats. Arch Pharm Res (2009) 0.75

Optimization of biotin labeling of antibodies using mouse IgG and goat anti-mouse IgG-conjugated fluorescent beads and their application as capture probes on protein chip. J Immunol Methods (2010) 0.75

A batch chemiluminescence determination of enoxacin using a tris-(1,10-phenanthroline)ruthenium(II)-cerium(IV) system. J Fluoresc (2006) 0.75

NMR assignments of the DNA-bound human Csx/Nkx2.5 homeodomain and NK2-specific domain. J Biomol NMR (2005) 0.75

Enhancing the processivity of a family B-type DNA polymerase of Thermococcus onnurineus and application to long PCR. Biotechnol Lett (2013) 0.75

Crystallization and preliminary X-ray studies of TON_0559, a putative member of the haloacid dehalogenase (HAD) superfamily from Thermococcus onnurineus NA1. Protein Pept Lett (2008) 0.75

Users' satisfaction on the electronic nursing record system. Stud Health Technol Inform (2006) 0.75

Crystal structure of (S)-3-hydroxybutyryl-CoA dehydrogenase from Clostridium butyricum and its mutations that enhance reaction kinetics. J Microbiol Biotechnol (2014) 0.75

Determination of malachite green and crystal violet in processed fish products. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2010) 0.75